BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/20/2024 3:53:47 AM | Browse: 38 | Download: 203
 |
Received |
|
2024-04-04 06:41 |
 |
Peer-Review Started |
|
2024-04-04 06:41 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2024-08-01 21:54 |
 |
Revised |
|
2024-08-30 08:18 |
 |
Second Decision |
|
2024-09-12 02:40 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2024-09-12 03:34 |
 |
Articles in Press |
|
2024-09-12 03:34 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
2024-12-02 13:41 |
 |
Typeset the Manuscript |
|
2024-12-12 07:58 |
 |
Publish the Manuscript Online |
|
2024-12-20 03:53 |
ISSN |
1007-9327 (print) and 2219-2840 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Basic Study |
Article Title |
In silico analysis of lncRNA-miRNA-mRNA signatures related to sorafenib effectiveness in liver cancer cells
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Patricia de la Cruz-Ojeda, Ester Parras-Martínez, Raquel Rey-Pérez and Jordi Muntané |
ORCID |
|
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
Instituto de Salud Carlos III (ISCiii) |
PI19/01266 and PI22/00857 |
Consejería de Salud y Familias (Junta de Andalucía) |
PI-0216-2020 and PIP-0215-2020 |
Biomedical Research Network Center for Liver and Digestive Diseases (CIBERehd) founded by the ISCIII and co-financed by European Regional Development Fund “A way to achieve Europe” ERDF |
|
|
Corresponding Author |
Jordi Muntané, PhD, Research Associate, Department of Oncology Surgery, Cell Therapy and Organ Transplantation, Institute of Biomedicine of Seville, Virgen del Rocio University Hospital, Avn. Manuel Siurot S/N, Seville 41013, Spain. jmuntane-ibis@us.es |
Key Words |
Cell culture; Hepatocellular carcinoma; Non-coding RNA; RNAseq; Sorafenib |
Core Tip |
In the current study, we investigated the differential lncRNA-miRNA-mRNA regulatory axes in HepG2 and SNU449 under Sorafenib treatment. The study identified lncRNA-miRNA regulatory axes leading to increased expression mRNA with positive (SMAD7, TIRARP, TFAP4, FAXDC2 and ADRB2) and negative (VEGFA) therapeutic effects in HepG2 and SNU449 under Sorafenib treatment. |
Publish Date |
2024-12-20 03:53 |
Citation |
<p>de la Cruz-Ojeda P, Parras-Martínez E, Rey-Pérez R, Muntané J. In silico analysis of lncRNA-miRNA-mRNA signatures related to sorafenib effectiveness in liver cancer cells. <i>World J Gastroenterol</i> 2025; 31(3): 95207</p> |
URL |
https://www.wjgnet.com/1007-9327/full/v31/i3/95207.htm |
DOI |
https://dx.doi.org/10.3748/wjg.v31.i3.95207 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345